Corrigan Catherine's Form 4 filing
Exponent Inc (EXPO) · filed Nov 18, 2025
- Accession no.
- 0000851520-25-000078
- Filed
- Nov 18, 2025
- Trade date
- Nov 17, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $344.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Corrigan CatherineCIK 0001552213 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | MOption exerciseAcquired | +3,225 | $25.41 | +$81,947.25 | 86,654 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −3,225 | $70.21 | −$226,427.25 | 83,429 | Direct | |
| Nov 17, 2025 | Common Stock | MOption exerciseAcquired | +2,380 | $29.05 | +$69,139 | 85,809 | Direct | |
| Nov 17, 2025 | Common Stock | SSaleDisposed | −1,675 | $70.74 | −$118,489.5 | 84,134 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Not applicable.
Referenced by the price of 2 transactions in Table II.